LENSAR (LNSR) vs QTREX Quantum (QTEX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
QTREX Quantum (QTEX) has outperformed LENSAR (LNSR) over the past year, gaining 34.1% versus a loss of 47.0%. Over five years, LNSR leads with a -14.2% price change compared with -30.2% for QTEX. QTREX Quantum is the larger company by market cap ($118.4 million vs $78.9 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LNSR | QTEX |
|---|---|---|
| Share price | $6.42 | $1.77 |
| Market cap | $78.88M | $118.39M |
| 1-day change | -0.47% | +4.43% |
| YTD return | -44.54% | +87.78% |
| 1-year return | -47.04% | +34.13% |
| 5-year return | -14.23% | -30.17% |
| P/E ratio (TTM) | 35.67 | — |
| EPS (TTM) | $0.18 | $-0.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.94 | $3.85 |
| 52-week low | $4.95 | $0.283 |
| Distance from 52-week high | -50.39% | -54.16% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +76.48% | +183.29% |
| Average volume | 102.04K | 8.21M |
| Shares outstanding | 12.29M | 67.08M |
| Employees | 150 | 34 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QTEX has outperformed LNSR by 81.2 percentage points over the past year.
About LENSAR
LNSR stock →LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.
Health Care · Medical/Dental Instruments · 150 employees
About QTREX Quantum
QTEX stock →QTREX Quantum Ltd., engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure and advanced connectivity solutions for the quantum computing industry in Israel and USA. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.
Health Care · Medical/Dental Instruments · 34 employees
LNSR vs QTEX FAQ
Which is bigger, LENSAR or QTREX Quantum?
QTREX Quantum (QTEX) is larger, with a market capitalization of $118.39M compared with $78.88M for LENSAR (LNSR).
Which stock has performed better over the past year, LNSR or QTEX?
QTEX returned +34.13% over the past 12 months, compared with -47.04% for LNSR (price return, excluding dividends). Past performance does not predict future results.
Are LENSAR and QTREX Quantum in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.